23.07.2014 07:00:53
|
AkzoNobel Q2 Results 2014
July 23, 2014
Volumes positive in all three Business Areas Revenue down 4 percent, mainly due to 5 percent adverse currency effectsOperating income €353 million (2013: €322 million) reflecting increased volume and benefits from improvement actions Return on sales (ROS) improved from 8.3 percent to 9.5 percent. Restructuring costs were €45 million (2013: €40 million). Excluding these, ROS is 10.7 percent (2013: 9.3 percent)Net income attributable to shareholders was €205 million (2013: €184 million on a comparable basis), mainly due to higher operating incomeAdjusted EPS increased 23 percent to €0.95 (2013: €0.77 adjusted for an incidental tax gain)Net cash inflow from operating activities was €393 million (2013: €261 million)On track to deliver 2015 targets despite a strong euro and the expected continued fragile economic environment in 2014Q2 2014 in € million
Q2 2013Q2 2014D% Revenue 3,865 3,710 (4) Operating income 322 353 10 Return on sales (ROS) % 8.3 9.5 EBITDA 474 509 7 Net income attributable to shareholders*184 205 11
H1 2014 in € million
H1 2013H1 2014D% Revenue 7,330 7,093 (3) Operating income 539 569 6 Return on sales (ROS) % 7.4 8.0 EBITDA 849 873 3 Net income attributable to shareholders* 280 334 19* Excluding discontinued operations and a deferred tax gain
Akzo Nobel N.V. (AkzoNobel) today reported positive volume development in all three Business Areas. Second quarter revenue of €3,710 million was 4 percent lower compared with the same quarter last year. The decrease was mainly due to 5 percent adverse currency effects.
Operating income improved 10 percent to €353 million (2013: €322 million), leading to an increase in net income attributable to shareholders of €205 million (2013: €184 million on a comparable basis). Excluding restructuring costs, return on sales improved in all three Business Areas, with an overall ROS of 9.5 percent (2013: 8.3 percent).
CEO Ton Büchner said:
"With the publication of the Q2 figures, the results of our ongoing commitment to organic growth and operational efficiency continue to be visible. We are operating in a volatile market, but we managed to increase volumes in all three Business Areas, and for the fourth consecutive quarter we saw positive progress in our year-on-year ROS. Compared to 2013, net income attributable to shareholders increased on a comparable basis. This quarter also highlighted some great examples of AkzoNobel's commitment to innovation and sustainability, such as the opening of our new membrane electrolysis plant in Germany, the €6.5 million investment to expand the research center at our Performance Coatings site in China, and the start-up of our new €80 million Imperatriz Chemical Island in Brazil. We also launched our Human Cities initiative. These developments will not only help to further enhance our operational efficiency and stimulate organic growth, but will also boost our market leading positions, ensuring that we are on track to deliver on our 2015 financial targets."
In Decorative Paints, volumes rose by 3 percent, mainly because of increased volumes in Asia and most European countries. Revenue declined 9 percent compared with 2013, due to the divestment of Building Adhesives and a 5 percent adverse currency effect. Operating income was at the same level as last year, although when the effect of divestments and adverse currency developments are excluded, it increased on a comparable basis. The ongoing operational excellence measures in Europe continue to support the improvements in margin.
Volumes in Performance Coatings rose 1 percent compared with 2013. Revenue declined 2 percent, with the improvements in volume and price/mix being offset by adverse currencies. Operating income improved 9 percent, due to operating effectiveness measures, which offset increased restructuring costs and an adverse currency impact. Return on sales was 12.4 percent (2013: 11 percent).
Volumes in Specialty Chemicals increased 4 percent due to better market conditions in most businesses, with Pulp and Performance Chemicals and Functional Chemicals showing strong growth. Revenue declined, mainly due to adverse currency developments and continued caustic price pressure. Operating income increased 2 percent compared with 2013 due to cost control and operational efficiencies.
Business area highlights
Decorative Paints Q2 2013 Q2 2014D% H1 2013 H1 2014D% 1,179 1,074 (9) Revenue 2,104 1,939 (8) 102 102 - Operating Income 145 119 (18) 8.7 9.5ROS % 6.9 6.1 141 141 - EBITDA 229 197 (14) Performance Coatings Q2 2013 Q2 2014D% H1 2013 H1 2014D% 1,458 1,434 (2) Revenue 2,789 2,753 (1) 163 178 9 Operating Income 292 304 4 11.2 12.4ROS % 10.5 11.0 197 212 8 EBITDA 360 375 4 Specialty Chemicals Q2 2013 Q2 2014D% H1 2013 H1 2014D% 1,253 1,228 (2) Revenue 2,497 2,450 (2) 121 124 2 Operating Income 220 259 18 9.7 10.1ROS % 8.8 10.6 198 204 3 EBITDA 372 408 10Outlook
We are on track to deliver on our 2015 targets despite a strong euro and the expected continued fragile economic environment in 2014.
The Q2 2014 report can be downloaded via the AkzoNobel Report iPad app http://bit.ly/obljrf or read online at www.akzonobel.com/quarterlyresults.
- - -
AkzoNobel is a leading global paints and coatings company and a major producer of specialty chemicals. We supply industries and consumers worldwide with innovative products and are passionate about developing sustainable answers for our customers. Our portfolio includes well-known brands such as Dulux, Sikkens, International and Eka. Headquartered in Amsterdam, the Netherlands, we are consistently ranked as one of the leaders in the area of sustainability. With operations in more than 80 countries, our 50,000 people around the world are committed to delivering leading products and technologies to meet the growing demands of our fast-changing world.
Not for publication - for more information
Corporate Media Relations Corporate Investor Relations T +31 (0)20 - 502 7833 T +31 (0)20 - 502 7854 Contact: Diana Abrahams Contact: Sheryl Stokes
Safe Harbor Statement
This press release contains statements which address key issues such as AkzoNobel's growth strategy, future financial results, market positions, product development, products in the pipeline and product approvals. Such statements should be carefully considered, and it should be understood that many factors could cause forecasted and actual results to differ from these statements. These factors include, but are not limited to, price fluctuations, currency fluctuations, developments in raw material and personnel costs, pensions, physical and environmental risks, legal issues, and legislative, fiscal, and other regulatory measures. Stated competitive positions are based on management estimates supported by information provided by specialized external agencies. For a more comprehensive discussion of the risk factors affecting our business please see our latest annual report, a copy of which can be found on our website www.akzonobel.com
AkzoNobel Press Release Q2 2014
This announcement is distributed by Nasdaq OMX Corporate Solutions on behalf of NASDAQ OMX Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Akzo Nobel NV via Globenewswire
HUG#1833792
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Akzo Nobel N.V.mehr Nachrichten
Keine Nachrichten verfügbar. |
Analysen zu Akzo Nobel N.V.mehr Analysen
23.10.24 | Akzo Nobel Buy | Jefferies & Company Inc. | |
23.10.24 | Akzo Nobel Buy | UBS AG | |
23.10.24 | Akzo Nobel Neutral | JP Morgan Chase & Co. | |
23.10.24 | Akzo Nobel Buy | Jefferies & Company Inc. | |
14.10.24 | Akzo Nobel Buy | UBS AG |